Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 21:9:1902.
doi: 10.3389/fmicb.2018.01902. eCollection 2018.

Acinetobacter nosocomialis: Defining the Role of Efflux Pumps in Resistance to Antimicrobial Therapy, Surface Motility, and Biofilm Formation

Affiliations

Acinetobacter nosocomialis: Defining the Role of Efflux Pumps in Resistance to Antimicrobial Therapy, Surface Motility, and Biofilm Formation

Daniel B Knight et al. Front Microbiol. .

Abstract

Acinetobacter nosocomialis is a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex. Increasingly, reports are emerging of the pathogenic profile and multidrug resistance (MDR) phenotype of this species. To define novel therapies to overcome resistance, we queried the role of the major efflux pumps in A. nosocomialis strain M2 on antimicrobial susceptibility profiles. A. nosocomialis strains with the following mutations were engineered by allelic replacement; ΔadeB, ΔadeJ, and ΔadeB/adeJ. In these isogenic strains, we show that the ΔadeJ mutation increased susceptibility to beta-lactams, beta-lactam/beta-lactamase inhibitors, chloramphenicol, monobactam, tigecycline, and trimethoprim. The ΔadeB mutation had a minor effect on resistance to certain beta-lactams, rifampicin and tigecycline. In addition, the ΔadeJ mutation resulted in a significant decrease in surface motility and a minor decrease in biofilm formation. Our results indicate that the efflux pump, AdeIJK, has additional roles outside of antibiotic resistance in A. nosocomialis.

Keywords: Acinetobacter; RND-efflux; antimicrobial resistance; biofilm; motility.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Surface motility of wild-type M2 and efflux mutants. Wild-type M2 and the isogenic adeB and adeJ mutants were assayed for surface motility as described in the Materials and Methods. In (A), motility of the indicated strains is shown after 14 h at 30°C. Motility was quantitated from 4 separate experiments at 30°C (B) and 37°C (C). Error bars represent standard deviation of the mean. N.S. indicates a p-value > 0.05.
Figure 2
Figure 2
Biofilm formation. Wild-type M2 and the isogenic adeB and adeJ mutants were assayed for biofilm formation in microtiter wells grown at 30 or 37°C for 24 h. Values represent crystal violet staining/cell density (A585 / A600) ratio and error bars represent standard deviation of the mean. N.S. indicates a p-value > 0.05.

Similar articles

Cited by

References

    1. Bahl C. D., Hvorecny K. L., Bridges A. A., Ballok A. E., Bomberger J. M., Cady K. C., et al. . (2014). Signature motifs identify an Acinetobacter Cif virulence factor with epoxide hydrolase activity. J. Biol. Chem. 289, 7460–7469. 10.1074/jbc.M113.518092 - DOI - PMC - PubMed
    1. Carruthers M. D., Harding C. M., Baker B. D., Bonomo R. A., Hujer K. M., Rather P. N., et al. . (2013). Draft genome sequence of the clinical isolate Acinetobacter nosocomialis strain M2. Genome Announc. 1:e00906-13 10.1128/genomeA.00906-13 - DOI - PMC - PubMed
    1. Chusri S., Chongsuvivatwong V., Rivera J. I., Silpapojakul K., Singkhamanan K., McNeil E., et al. . (2014). Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii. Antimicrob. Agents Chemother. 58, 4172–4179. 10.1128/AAC.02992-14 - DOI - PMC - PubMed
    1. Clemmer K. M., Bonomo R. A., Rather P. N. (2011). Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology 157, 2534–2544. 10.1099/mic.0.049791-0 - DOI - PMC - PubMed
    1. Damier-Piolle L., Magnet S., Bremont S., Lambert T., Courvalin P. (2008). AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob. Agents Chemother. 52, 557–562. 10.1128/AAC.00732-07 - DOI - PMC - PubMed

LinkOut - more resources